PLX Earnings

PLX reported its FY2025Q3 earnings on 2025-11-13, showcasing a revenue of 17.85M against an estimate of 17.87M, resulting in a -0.08% surprise. The EPS was 0.03, surpassing the expected 0.05 by -40% . The stock experienced a -9.81% price change on the earnings day and a -12.15% change over the next five days, reflecting market reactions to the results.

Following PLX's FY2025Q3 earnings announcement on 2025-11-13, the stock price moved by -9.81% on the day of the release. Over the subsequent five days, it saw a -12.15% change. Historically, PLX's stock price tends to shift by an average of +7.94% in the 10 days leading up to earnings and -1.35% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate PLX’s annual revenue to reach 16.80M, while the EPS is projected at 0.04. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 2.62% and EPS estimates Revise Upward by 10.11% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between PLX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 2.62%, while EPS estimates moved Revise Upward by 10.11% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PLX's stock price typically moves by +7.94% in the 10 days before its earnings and -1.35% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.04 and revenue of 16.80M.

The earnings call reveals mixed signals: increased R&D expenses and net loss improvement are positive, but unclear responses on revenue guidance and cash burn are concerning. The positive outlook for PRX-115's market potential and Elfabrio's potential EMA approval are offset by limited visibility on financial metrics. The Q&A section highlights uncertainties, with management's evasive answers potentially dampening investor confidence. Overall, the stock is likely to remain stable, resulting in a neutral sentiment.